My Pharmaceutical

How Will IoT Revolutionize Pharmaceutical Manufacturing? Read Infiniti’s Latest Blog for More Insights

Despite technological advancements, the pressing matter pharma companies have to address is how to achieve more control over their operations within and outside the facilities to remain competitive, optimize time-to-market, avoid shipment delays, and reduce the waste.

Posted in My Pharmaceutical | Tagged | Leave a comment

PCSK9is shown to lower improve cardiovascular outcomes, many rejected by their insurance plan

New research from the FH Foundation highlights that individuals at high risk for cardiovascular events, including those with familial hypercholesterolemia (FH) or atherosclerotic cardiovascular disease (ASCVD), experienced more heart attacks, strokes and other cardiovascular events when they were unable to obtain their prescribed PCSK9 inhibitor (PCSK9i), a cholesterol-lowering treatment.

Posted in My Pharmaceutical, news, North America | Tagged | Leave a comment

2019 Hansen Family Award goes to Professor Edith Heard

The award-winner of the 2019 Hansen Family Award is Professor Edith Heard. The Board of Trustees of the Bayer Science & Education Foundation and the Scientific Committee for this award have presented her with one of Germany’s most prestigious scientific accolades including a prize money of EUR 75,000.

Posted in Europe, My Pharmaceutical | Tagged | Leave a comment

Natural ingredients show beneficial effects on cardiovascular health and sports performance

Euromed, a Spain-based producer of standardized herbal extracts and natural active substances for pharmaceutical, nutraceutical and cosmetic industries, said Wednesday that, according to a recently published randomised, double-blind, placebo-controlled study, supplementation with Euromed’s natural extracts Pomanox™ and Mediteanox™ could help to maintain a healthy blood pressure, endothelial function and levels of circulating oxidised low-density lipoprotein cholesterol (oxLDL).

Posted in Australia, Europe, Latin America, Middle East and North Africa, My Pharmaceutical, North America | Tagged , | Leave a comment

Boys and Girls Clubs of Canada Join the Fight Against the Opioid Crisis in National Partnership with Adapt Pharma Canada

Boys and Girls Clubs of Canada (BGCC) has partnered with NARCAN Nasal Spray manufacturers, Adapt Pharma Canada, in the continued fight against the devastating fallout of Canada’s opioid crisis.

Posted in My Pharmaceutical, North America | Tagged , , | Leave a comment

Reducing severity of Rheumatoid Arthritis

by: Lucy WyndhamYoga can Reduce the Severity of Rheumatoid Arthritis There are over 1.3 million Americans battling rheumatoid arthritis (RA)

Posted in My Pharmaceutical | Tagged , | Leave a comment

Is Your Candle Habit Making You Sick?

The Business of Fashion claims that the candle market has risen by more than thirty percent over the last two years, and for good reason. Scented candles are comforting, great for setting the mood, and making your home smell down right delicious, but the dangers of scented paraffin candles might not be worth their mood-boosting qualities, as inhaling what they give off could be damaging to the lungs and more.

Posted in My Pharmaceutical, news | Leave a comment

Consequences of microbead: What makes microbeads problematic

In the world of great discoveries that cure or add a positive element to our everyday existence, the invention of microbeads hasn’t proven to be one of them. Not alone in its quick rise to popularity and slow journey to extinction, the microbead is just one of numerous products rushed to market before its long term effects are uncovered.

Posted in Approval, My Pharmaceutical | Tagged | Leave a comment

UKCloud Health joins the Global Alliance for Genomics and Health

UKCloud Health, the easy to adopt, use, and leave assured cloud services company, today announced that it has become a

Posted in My Pharmaceutical | Tagged | Leave a comment

Better prevention can curbe significant disruption to daily life and work caused by migraine

Novartis and the European Migraine and Headache Alliance (EMHA) Wednesday presented initial findings from the largest global migraine patient study

Posted in Approval, My Pharmaceutical, news | Leave a comment

<script async src=”//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js”></script>
<ins class=”adsbygoogle”
(adsbygoogle = window.adsbygoogle || []).push({});

<amp-auto-ads type=”adsense”